Thryvv : ratio page

Kwality Pharma

Overview Articles News Financials Ratios Shareholding Peers

Financial Ratios

View
Order
Financial Ratios
Mar2024
Mar2023
Mar2022
Mar2021
Mar2020
Valuation Parameters:
PE(x)
17.85
16.47
5.02
3.84
3.19
PCE(x)
9.84
9.32
4.61
2.72
2.10
Price/Book(x)
1.90
1.60
3.34
0.96
0.59
Yield(%)
0.00
0.00
0.00
0.00
0.00
EV/Net Sales(x)
1.68
1.60
1.41
0.36
0.43
EV/Core EBITDA(x)
7.59
6.31
3.67
3.07
3.36
EV/EBIT(x)
12.46
12.49
3.91
3.91
4.47
EV/CE(x)
1.61
1.39
1.89
0.56
0.45
MCap / Sales
1.38
1.27
1.32
0.22
0.19
Growth Ratio:
Net Sales Growth(%)
22.36
-44.97
74.11
88.10
-16.23
Core EBITDA Growth(%)
7.03
-63.65
475.48
70.50
9.45
EBIT Growth(%)
28.92
-80.44
586.87
78.45
1.71
PAT Growth(%)
22.49
-83.93
705.63
81.40
8.60
EPS Growth(%)
22.83
-83.86
692.23
82.11
10.13
Financial Stability Ratios:
Total Debt/Equity(x)
0.44
0.45
0.30
0.68
0.77
Current Ratio(x)
1.60
1.65
1.63
1.35
1.31
Quick Ratio(x)
1.08
0.96
1.25
1.14
1.00
Interest Cover(x)
3.99
4.87
56.38
8.95
5.36
Total Debt/Mcap(x)
0.23
0.28
0.09
0.71
1.32
Operational & Financial Ratios:
Earnings Per Share (Rs)
22.93
18.67
115.64
14.60
8.02
CEPS(Rs)
41.61
33.00
125.89
20.61
12.18
DPS(Rs)
0.00
0.00
0.00
0.00
0.00
Book NAV/Share(Rs)
215.31
192.48
173.81
58.16
43.57
Tax Rate(%)
24.06
24.61
25.77
30.01
24.83
Margin Ratios:
Core EBITDA Margin(%)
21.59
24.19
37.63
11.01
10.19
EBIT Margin(%)
13.51
12.82
36.06
9.14
9.63
Pre Tax Margin(%)
10.12
10.19
35.42
8.12
7.84
PAT Margin (%)
7.69
7.68
26.29
5.68
5.89
Cash Profit Margin (%)
14.06
13.64
28.64
8.16
9.07
Performance Ratios:
ROA(%)
6.32
5.55
47.33
9.97
6.90
ROE(%)
11.16
10.15
99.66
28.21
20.10
ROCE(%)
13.57
12.27
97.93
26.35
18.46
Asset Turnover(x)
0.82
0.72
1.80
1.75
1.17
Sales/Fixed Asset(x)
1.63
1.68
4.34
3.62
2.69
Working Capital/Sales(x)
3.38
3.09
5.16
9.49
6.55
Efficiency Ratios:
Fixed Capital/Sales(x)
0.61
0.59
0.23
0.28
0.37
Receivable days
110.56
102.38
41.94
46.00
90.08
Inventory Days
97.85
101.54
28.29
27.71
44.10
Payable days
161.90
183.20
78.14
54.20
83.90